Related Experiment Video

Updated: Jun 8, 2025

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations
10:26

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations

Published on: November 7, 2019

5.5K

Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance

Kai Sun1,2, Yuan Zhi1, Wenhao Ren1,2,3

  • 1Department of Oral and Maxillofacial Reconstruction, The Affiliated Hospital of Qingdao University, 1677 Wutaishan Road, Huangdao Distract, Qingdao, 266003, Shandong, China.

Experimental Hematology & Oncology
|November 2, 2024
PubMed

Insights

Understanding how O-GlcNAcylation and ubiquitination impact cancer treatment resistance is key. Targeting these pathways offers new strategies to overcome drug resistance and improve patient outcomes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Therapeutic resistance is a major obstacle in cancer treatment, often causing recurrence and metastasis.
  • O-GlcNAcylation and ubiquitination are critical post-translational modifications involved in regulating protein function and cellular signaling.
  • The interplay between these two modifications is increasingly recognized for its role in cancer progression and treatment resistance.

Purpose of the Study:

  • To review recent discoveries on the roles of O-GlcNAcylation and ubiquitination in cancer resistance.
  • To explore the interactions between O-GlcNAcylation and ubiquitination in the context of cancer.
  • To discuss potential therapeutic strategies targeting these pathways to overcome treatment resistance.

Main Methods:

  • Literature review of recent research on O-GlcNAcylation and ubiquitination in cancer.
  • Analysis of studies investigating the interplay between these modifications.
  • Synthesis of findings related to mechanisms of resistance and therapeutic targeting.

Main Results:

  • O-GlcNAcylation and ubiquitination significantly influence cancer cell signaling and survival.
  • Their combined activity is linked to the development of resistance to various cancer therapies.
  • Specific molecular mechanisms underlying this interplay are being elucidated.

Conclusions:

  • Targeting O-GlcNAcylation and ubiquitination pathways presents a promising avenue for overcoming cancer treatment resistance.
  • Further research into these modifications could lead to novel therapeutic interventions.
  • Understanding these complex regulatory networks is crucial for advancing cancer therapy.
Keywords:
CancerInteractionO-GlcNAcylationTherapeutic resistanceUbiquitination

More Related Videos

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

2.5K
In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

10.7K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K